|
|
|
|
A more recent version of this article appeared on January 1, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 22, 2004
Revised on September 15, 2004
Accepted on September 27, 2004
Department of Internal Medicine IV, Ruprechts-Karls-University, D-69117 Heidelberg, Germany
Monitoring Editor: Guido Guidotti
We previously reported that lipid rafts are involved in long-chain fatty acid (LCFA) uptake in 3T3-L1 adipocytes.The present data show that LCFA uptake does not depend on caveolae endocytosis as expression of a dominant negative mutant of dynamin had no effect on uptake of [3H] oleic acid while it effectively prevented endocytosis of cholera toxin. Isolation of detergent-resistant membranes (DRMs) from 3T3-L1 cell homogenates revealed that FAT/CD36 was expressed in both DRMs and detergent soluble membranes (DSMs) while FATP1 and FATP4 were present only in DSM but not DRMs. Disruption of lipid rafts by cyclodextrin and specific inhibition of FAT/CD36 by sulfo-N-succinimidyl oleate (SSO) significantly decreased uptake of [3H]oleic acid but simultaneous treatment had no additional or synergistic effects suggesting that both treatments target the same mechanism. Indeed, subcellular fractionation demonstrated that plasma membrane fatty acid translocase (FAT/CD36) is exclusively located in lipid rafts while intracellular FAT/CD36 cofractionated with DSMs. Binding assays confirmed that [3H]SSO predominantly binds to FAT/CD36 within plasma membrane DRMs. In conclusion, our data strongly suggest that FAT/CD36 mediates raft-dependent LCFA uptake. Plasma membrane lipid rafts might control LCFA uptake by regulating surface availability of FAT/CD36.
This article has been cited by other articles:
![]() |
L. Qiao, C. Zou, P. Shao, J. Schaack, P. F. Johnson, and J. Shao Transcriptional Regulation of Fatty Acid Translocase/CD36 Expression by CCAAT/Enhancer-binding Protein {alpha} J. Biol. Chem., April 4, 2008; 283(14): 8788 - 8795. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Martin, E. Longman, C. Wooding, S. J. Hoosdally, S. Ali, T. J. Aitman, D. A.P. Gutmann, P. S. Freemont, B. Byrne, and K. J. Linton Cd36, a class B scavenger receptor, functions as a monomer to bind acetylated and oxidized low-density lipoproteins Protein Sci., November 1, 2007; 16(11): 2531 - 2541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Kampf, D. Parmley, and A. M. Kleinfeld Free fatty acid transport across adipocytes is mediated by an unknown membrane protein pump Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1207 - E1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. N. Changolkar, C. Costanzi, N. A. Leu, D. Chen, K. J. McLaughlin, and J. R. Pehrson Developmental Changes in Histone macroH2A1-Mediated Gene Regulation Mol. Cell. Biol., April 1, 2007; 27(7): 2758 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Eyre, L. G. Cleland, N. N. Tandon, and G. Mayrhofer Importance of the carboxyl terminus of FAT/CD36 for plasma membrane localization and function in long-chain fatty acid uptake J. Lipid Res., March 1, 2007; 48(3): 528 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bonen, A. Chabowski, J. J. F. P Luiken, and J. F. C. Glatz Mechanisms and Regulation of Protein-Mediated Cellular Fatty Acid Uptake: Molecular, Biochemical, and Physiological Evidence Physiology, February 1, 2007; 22(1): 15 - 28. [Full Text] [PDF] |
||||
![]() |
W. Guo, N. Huang, J. Cai, W. Xie, and J. A. Hamilton Fatty acid transport and metabolism in HepG2 cells Am J Physiol Gastrointest Liver Physiol, March 1, 2006; 290(3): G528 - G534. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Veluthakal, I. Chvyrkova, M. Tannous, P. McDonald, R. Amin, T. Hadden, D. C. Thurmond, M. J. Quon, and A. Kowluru Essential Role for Membrane Lipid Rafts in Interleukin-1{beta}-Induced Nitric Oxide Release From Insulin-Secreting Cells: Potential Regulation by Caveolin-1+ Diabetes, September 1, 2005; 54(9): 2576 - 2585. [Abstract] [Full Text] [PDF] |
||||